Gene · 21
NIH grants938
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 938
Download this page as JSON| Grant | Title | ABCA3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL139897 | Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells | 1 | 2025 |
| R01HL141174 | Transcriptional Regulation of Endothelial Cells after Neonatal Lung Injury | 1 | 2025 |
| R01HL141278 | Alternative Protein Isoforms in Ventricular Remodeling | 1 | 2025 |
| R01HL141371 | Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy | 1 | 2025 |
| R01HL145372 | Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis | 1 | 2025 |
| R01HL152077 | Defining the Role of Regulatory T Cells in Resolution of Acute Lung Injury | 1 | 2025 |
| R01HL152973 | Development of novel therapeutic approaches for treatment of Alveolar Capillary Dysplasia | 1 | 2025 |
| R01HL153375 | Molecular control of a novel transitional cell state in alveolar regeneration | 1 | 2025 |
| R01HL155749 | Leveraging Variant-perturbed Gene Regulation to Support Precision Medicine in COPD | 1 | 2025 |
| R01HL157176 | Sox9 Regulation of Fibroblast Activation and Pulmonary Fibrosis | 1 | 2025 |
| R01HL157450 | The Role of Iron In Pulmonary Fibrosis | 1 | 2025 |
| R01HL158965 | Gene regulatory networks in early lung epithelial cell fate decisions | 1 | 2025 |
| R01HL164414 | Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation | 1 | 2025 |
| R01HL166139 | Functional interrogation of a novel SCGB3A2+/SFTPB+ cell in the human airway | 1 | 2025 |
| R01HL171035 | Adenine Base Edited Correction of Cystic Fibrosis Airways | 1 | 2025 |
| R24GM145965 | Resource for Macromolecular Modeling and Visualization | 1 | 2025 |
| R25ES025476 | Colorado Undergraduate Research in Environmental Health Sciences | 1 | 2025 |
| R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 1 | 2025 |
| R35CA232109 | Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy | 1 | 2025 |
| R35GM131707 | Control of cell proliferation and differentiation by growth pathways | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/grants?page=6